Patient Safety Organizations: Expired Listing for The American Cancer Biorepository, Inc. d/b/a American Collaborative Biorepository or “ACB”, 32975 [2012-13307]
Download as PDF
32975
Federal Register / Vol. 77, No. 107 / Monday, June 4, 2012 / Notices
OWH is requesting two years of OMB
approval to enable sampling, screening,
and survey implementation.
ESTIMATED ANNUALIZED BURDEN TABLE
Number
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondent
Form name
Medical Secretary .............................
Physician ...........................................
Screener ...........................................
Survey ..............................................
1,300
600
1
1
5/60
20/60
108
200
Total ...........................................
...........................................................
........................
........................
........................
308
Keith A. Tucker,
Office of the Secretary, Paperwork Reduction
Act Clearance Officer.
[FR Doc. 2012–13396 Filed 6–1–12; 8:45 am]
BILLING CODE 4150–33–P
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Background
Agency for Healthcare Research and
Quality
Patient Safety Organizations: Expired
Listing for The American Cancer
Biorepository, Inc. d/b/a American
Collaborative Biorepository or ‘‘ACB’’
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of delisting.
AGENCY:
AHRQ has delisted The
American Cancer Biorepository, Inc.
d/b/a American Collaborative
Biorepository or ‘‘ACB’’ as a Patient
Safety Organization (PSO) due to its
failure to seek continued listing. The
Patient Safety and Quality Improvement
Act of 2005 (Patient Safety Act)
authorizes the listing of PSOs, which are
entities or component organizations
whose mission and primary activity is
to conduct activities to improve patient
safety and the quality of health care
delivery. HHS issued the Patient Safety
and Quality Improvement Final Rule
(Patient Safety Rule) to implement the
Patient Safety Act. AHRQ administers
the provisions of the Patient Safety Act
and Patient Safety Rule relating to the
listing and operation of PSOs.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12 Midnight
ET (2400) on April 21, 2012.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT:
Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ,
ebenthall on DSK5SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:10 Jun 01, 2012
Jkt 226001
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; Email:
pso@AHRQ.hhs.gov.
Dated: May 22, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–13307 Filed 6–1–12; 8:45 am]
BILLING CODE 4160–90–M
Frm 00048
Agency for Healthcare Research and
Quality
AHRQ Workgroups on ICD–10–CM/
PCS Conversion of Quality Indicators
(QIs)
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of request for
nominations.
AGENCY:
The Patient Safety Act, Public Law
109–41, 42 U.S.C. 299b–21—b–26,
provides for the formation of PSOs,
which collect, aggregate, and analyze
confidential information regarding the
quality and safety of health care
delivery. The Patient Safety Rule, 42
CFR part 3, authorizes AHRQ, on behalf
of the Secretary of HHS, to list as a PSO
an entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety Act and Patient Safety Rule.
Section 3.108(d) of the Patient Safety
Rule requires AHRQ to provide public
notice when it removes an organization
from the list of federally approved
PSOs. Accordingly, The American
Cancer Biorepository, Inc. d/b/a
American Collaborative Biorepository or
‘‘ACB’’, PSO number P0036, was
delisted effective at 12:00 Midnight ET
(2400) on April 21, 2012.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.AHRQ.gov/
index.html.
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Fmt 4703
Sfmt 4703
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
nominations for members of
approximately 10 multidisciplinary
workgroups, to be convened by AHRQ’s
contractor, on ICD–10–CM/PCS
conversion of the AHRQ Quality
Indicators (QIs).
DATES: Please submit nominations on or
before June 29, 2012. Self-nominations
are welcome. Third-party nominations
must indicate that the individual has
been contacted and is willing to serve
on the workgroup. Selected candidates
will be notified no later than July 13,
2012.
ADDRESSES: Nominations can be sent in
the form of a letter or email, preferably
as an electronic file with an email
attachment and should specifically
address the submission criteria as noted
below. Electronic submissions are
strongly encouraged. Responses should
be submitted to: ATTN: John Bott,
Agency for Healthcare Research and
Quality, Center for Delivery,
Organization and Markets, 540 Gaither
Road, Room 5119, Rockville, MD 20850,
Email: john.bott@AHRQ.hhs.gov.
FOR FURTHER INFORMATION CONTACT: John
Bott, Agency for Healthcare Research
and Quality, Center for Delivery,
Organization and Markets, 540 Gaither
Road, Room 5119, Rockville, MD 20850,
Email: john.bott@AHRQ.hhs.gov; Phone:
(301) 427–1317; Fax: (301) 427–1430.
SUPPLEMENTARY INFORMATION: These
workgroups are being formed as part of
a structured approach for converting the
SUMMARY:
E:\FR\FM\04JNN1.SGM
04JNN1
Agencies
[Federal Register Volume 77, Number 107 (Monday, June 4, 2012)]
[Notices]
[Page 32975]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-13307]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Expired Listing for The American
Cancer Biorepository, Inc. d/b/a American Collaborative Biorepository
or ``ACB''
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of delisting.
-----------------------------------------------------------------------
SUMMARY: AHRQ has delisted The American Cancer Biorepository, Inc. d/b/
a American Collaborative Biorepository or ``ACB'' as a Patient Safety
Organization (PSO) due to its failure to seek continued listing. The
Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act)
authorizes the listing of PSOs, which are entities or component
organizations whose mission and primary activity is to conduct
activities to improve patient safety and the quality of health care
delivery. HHS issued the Patient Safety and Quality Improvement Final
Rule (Patient Safety Rule) to implement the Patient Safety Act. AHRQ
administers the provisions of the Patient Safety Act and Patient Safety
Rule relating to the listing and operation of PSOs.
DATES: The directories for both listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. The delisting was effective at 12 Midnight
ET (2400) on April 21, 2012.
ADDRESSES: Both directories can be accessed electronically at the
following HHS Web site: https://www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT: Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD
20850; Telephone (toll free): (866) 403-3697; Telephone (local): (301)
427-1111; TTY (toll free): (866) 438-7231; TTY (local): (301) 427-1130;
Email: pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act, Public Law 109-41, 42 U.S.C. 299b-21--b-26,
provides for the formation of PSOs, which collect, aggregate, and
analyze confidential information regarding the quality and safety of
health care delivery. The Patient Safety Rule, 42 CFR part 3,
authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an
entity that attests that it meets the statutory and regulatory
requirements for listing. A PSO can be ``delisted'' by the Secretary if
it is found to no longer meet the requirements of the Patient Safety
Act and Patient Safety Rule. Section 3.108(d) of the Patient Safety
Rule requires AHRQ to provide public notice when it removes an
organization from the list of federally approved PSOs. Accordingly, The
American Cancer Biorepository, Inc. d/b/a American Collaborative
Biorepository or ``ACB'', PSO number P0036, was delisted effective at
12:00 Midnight ET (2400) on April 21, 2012.
More information on PSOs can be obtained through AHRQ's PSO Web
site at https://www.pso.AHRQ.gov/.
Dated: May 22, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012-13307 Filed 6-1-12; 8:45 am]
BILLING CODE 4160-90-M